- The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. de Grooth, G.J., Zerba, K.E., Huang, S.P., Tsuchihashi, Z., Kirchgessner, T., Belder, R., Vishnupad, P., Hu, B., Klerkx, A.H., Zwinderman, A.H., Jukema, J.W., Sacks, F.M., Kastelein, J.J., Kuivenhoven, J.A. J. Am. Coll. Cardiol. (2004)